| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/07/2001 | US6270988 Transforming escherichia host cells with an extrachromosomal expression vector containing a dna sequence coding a transfer rna for arginine incorporation into proteins; treating the transformed cells resulting in favorable protein production |
| 08/07/2001 | US6270987 Glycosylating an epidermal growth factor domain of a polypeptide with an activated o-frucose; cancer diagnosis |
| 08/07/2001 | US6270960 Detecting microorganism in sample; incubate sample with preferential polypeptide and detect binding of preferential antibody |
| 08/07/2001 | US6270956 Polypeptide activator of gene expression; for use in treatment of preferential viral diseases and infections; for the detection of modulators of gene expression |
| 08/07/2001 | US6270778 Relates to genes encoding melanoma antigens recognized by t-cells and their corresponding proteins. |
| 08/07/2001 | US6270776 Recombinant mycobacterial vaccine |
| 08/07/2001 | US6270772 Mhc class ii based molecules that comprise covalently linked beta 1 and alpha 1 domains, and mhc class i based molecules that comprise covalently linked alpha 1 and alpha 2 domains. |
| 08/07/2001 | US6270767 Isolated and/or purified monoclonal or polyclonal antibodies obtained by immunological reaction of human or animal organism to immunogenic agent that binds to anti-trypanosoma cruzi antisera, said agent being cytoplasmic protein of trypanosoma |
| 08/07/2001 | US6270765 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 08/07/2001 | US6270763 Recombinant products are useful for diagnosis of allergy and for therapeutic treatment of allergy. |
| 08/07/2001 | CA2044746C Polypeptide compound and a process for preparation thereof |
| 08/07/2001 | CA1341281C Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen |
| 08/02/2001 | WO2001055449A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055440A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055411A2 Human sulfatases |
| 08/02/2001 | WO2001055396A1 NOVEL POLYPEPTIDES HmrA AND HmrB |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055392A2 Nuclear hormone receptors |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055389A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 08/02/2001 | WO2001055388A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055333A2 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055329A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055306A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055298A2 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins |
| 08/02/2001 | WO2001055217A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | WO2001055216A1 Methods and compositions for generating human monoclonal antibodies |
| 08/02/2001 | WO2001055211A2 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001054732A1 Antibodies against ctla4 (cd152), conjugates comprising same, and uses thereof |
| 08/02/2001 | WO2001054722A1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001004144A3 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2001000804A3 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 08/02/2001 | WO2000070036A3 Genes expressed in hippocampus |
| 08/02/2001 | WO2000065070A9 Cell culture process for glycoproteins |
| 08/02/2001 | WO2000055191A3 Recombinant haemophilus influenzae adhesin proteins |
| 08/02/2001 | WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/02/2001 | WO2000047715A9 Dwf4 polynucleotides, polypeptides and uses thereof |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | WO2000026241A9 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/02/2001 | WO2000023602A3 Regulated expression using conditional er retention domains |
| 08/02/2001 | US20010011125 Genetic engineering; grafting antibodies |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010010935 Useful in treating stem cells in a patient undergoing chemotherapy |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010929 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 08/02/2001 | US20010010928 Protozoan expression system |
| 08/02/2001 | US20010010927 A method for screening candidate pesticides using a receptor that binds bacillus thuringiensis toxin |
| 08/02/2001 | US20010010926 New immunoregulatory protein lst-1 |
| 08/02/2001 | US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's |
| 08/02/2001 | US20010010920 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | US20010010908 Reagents and methods useful for detecting diseases of the prostate |
| 08/02/2001 | US20010010904 Genetic engineering; overlapping Dna sequences |
| 08/02/2001 | US20010010901 Genetic engineering |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398564A1 Nuclear hormone receptors |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398466A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398284A1 Methods and compositions for generating human monoclonal antibodies |
| 08/02/2001 | CA2398242A1 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2397735A1 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins |
| 08/02/2001 | CA2395857A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | CA2395811A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395676A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393954A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393941A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2366828A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 08/01/2001 | EP1120466A2 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/01/2001 | EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 08/01/2001 | EP1120426A1 Novel g protein-coupled receptors |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 08/01/2001 | EP0889959B1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 08/01/2001 | EP0862629B1 Epithelial membrane protein-1 |
| 08/01/2001 | EP0777489B1 Low molecular yeast active substance extract and process for preparing the same |
| 08/01/2001 | EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 08/01/2001 | EP0654532B1 Antimucoglycoprotein monoclonal antibody |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 08/01/2001 | CN1306574A Attenuated virus oka strain gene 62 and method for identifying virus strain for attenuated live vaccine by using same |
| 08/01/2001 | CN1306573A Novel human thrombopoietin mutein |
| 08/01/2001 | CN1306572A Soluble T cell receptor |
| 08/01/2001 | CN1306542A Moraxella catharralis proteins |
| 08/01/2001 | CN1306437A Vaccine |
| 08/01/2001 | CN1306007A Dry cell factor |